Cikkek nyilvánosan hozzáférhető megbízással - Erik Fink EriksenTovábbi információ
Sehol sem hozzáférhető: 2
Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review
EF Eriksen, A Díez-Pérez, S Boonen
Bone 58, 126-135, 2014
Megbízások: Research Foundation (Flanders)
Beta-ecdysone protects mouse osteoblasts from glucocorticoid-induced apoptosis in vitro
WW Dai, LB Wang, GQ Jin, HJ Wu, J Zhang, CL Wang, YJ Wei, JH Lee, ...
Planta medica 83 (11), 888-894, 2017
Megbízások: US National Institutes of Health
Valahol hozzáférhető: 22
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
DM Black, PD Delmas, R Eastell, IR Reid, S Boonen, JA Cauley, ...
New England Journal of Medicine 356 (18), 1809-1822, 2007
Megbízások: Versus Arthritis, UK
Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS
E Tsourdi, B Langdahl, M Cohen-Solal, B Aubry-Rozier, EF Eriksen, ...
Bone 105, 11-17, 2017
Megbízások: UK Medical Research Council
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH (1–34)] in postmenopausal osteoporosis
F Cosman, EF Eriksen, C Recknor, PD Miller, N Guañabens, C Kasperk, ...
Journal of Bone and Mineral Research 26 (3), 503-511, 2011
Megbízások: Research Foundation (Flanders)
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG …
P Hadji, MS Aapro, JJ Body, M Gnant, ML Brandi, JY Reginster, ...
Journal of bone oncology 7, 1-12, 2017
Megbízások: UK Medical Research Council, National Institute for Health Research, UK
Potential mediators of the mortality reduction with zoledronic acid after hip fracture
CS Colón‐Emeric, P Mesenbrink, KW Lyles, CF Pieper, S Boonen, ...
Journal of Bone and Mineral Research 25 (1), 91-97, 2010
Megbízások: US National Institutes of Health, Research Foundation (Flanders)
Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture
EF Eriksen, KW Lyles, CS Colón‐Emeric, CF Pieper, JS Magaziner, ...
Journal of bone and mineral research 24 (7), 1308-1313, 2009
Megbízások: US National Institutes of Health
Efficacy and safety of a once‐yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older
S Boonen, DM Black, CS Colón‐Emeric, R Eastell, JS Magaziner, ...
Journal of the American Geriatrics Society 58 (2), 292-299, 2010
Megbízások: US National Institutes of Health, Research Foundation (Flanders)
Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long‐term continuation on bone turnover and fracture risk—a perspective
S Boonen, S Ferrari, PD Miller, EF Eriksen, PN Sambrook, J Compston, ...
Journal of Bone and Mineral Research 27 (5), 963-974, 2012
Megbízások: Research Foundation (Flanders)
Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women
S Boonen, DE Sellmeyer, K Lippuner, A Orlov-Morozov, K Abrams, ...
Kidney international 74 (5), 641-648, 2008
Megbízások: Research Foundation (Flanders)
International osteoporosis foundation and european calcified tissue society working group. Recommendations for the screening of adherence to oral bisphosphonates
A Diez-Perez, KE Naylor, B Abrahamsen, D Agnusdei, ML Brandi, ...
Osteoporosis International 28, 767-774, 2017
Megbízások: Versus Arthritis, UK, UK Medical Research Council, National Institute for …
Bone material properties in actively bone‐forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once‐yearly zoledronic acid
S Gamsjaeger, B Buchinger, E Zwettler, R Recker, D Black, JA Gasser, ...
Journal of Bone and Mineral Research 26 (1), 12-18, 2011
Megbízások: Austrian Science Fund
Recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentation
A Diez-Perez, ML Bouxsein, EF Eriksen, S Khosla, JS Nyman, ...
Bone reports 5, 181-185, 2016
Megbízások: US National Institutes of Health
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
R Eastell, T Lang, S Boonen, S Cummings, PD Delmas, JA Cauley, ...
Osteoporosis international 21, 1277-1285, 2010
Megbízások: Research Foundation (Flanders), Canadian Institutes of Health Research …
Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
S Gamsjaeger, B Hofstetter, E Zwettler, R Recker, JA Gasser, EF Eriksen, ...
Osteoporosis International 24, 339-347, 2013
Megbízások: Austrian Science Fund
Posterior circulation stroke diagnosis using HINTS in patients presenting with acute vestibular syndrome: A systematic review
K Krishnan, K Bassilious, E Eriksen, PM Bath, N Sprigg, SK Brækken, ...
European Stroke Journal 4 (3), 233-239, 2019
Megbízások: National Institute for Health Research, UK
Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial
JD Adachi, KW Lyles, CS Colón-Emeric, S Boonen, CF Pieper, ...
Osteoporosis international 22, 2539-2549, 2011
Megbízások: Research Foundation (Flanders)
Skeletal effects of plyometric exercise and metformin in ovariectomized rats
AK Stunes, RG Erben, C Schüler, EF Eriksen, M Tice, D Vashishth, ...
Bone 132, 115193, 2020
Megbízások: US National Institutes of Health
Adding marrow adiposity and cortical porosity to femoral neck areal bone mineral density improves the discrimination of women with nonvertebral fractures from controls
R Zebaze, M Osima, M Bui, M Lukic, X Wang, A Ghasem‐Zadeh, ...
Journal of Bone and Mineral Research 34 (8), 1451-1460, 2019
Megbízások: National Health and Medical Research Council, Australia, Research Council of …
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.